SectorBiological Technology
Established Date01/12/2017
Listing Date17/09/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees258
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1560 Trapelo Road, Waltham, Massachusetts 02451
Business
IntroductionDyne Therapeutics, Inc., was incorporated under the laws of the State of Delaware on December 1, 2017. The company is building a leading muscle disease company dedicated to developing innovative life-changing therapies for patients with genetically driven diseases. The company is leveraging its proprietary FORCE platform to overcome the limitations of current muscle tissue delivery and develop modern oligonucleotide therapies for muscle diseases.
